Latest News

Participants in the ninth IAS Conference on HIV science walk through the halls in Paris on Monday. (Michel Euler/AP)

CommonHealth

21 mins ago

'Mosaic' HIV Vaccine Looks Good In Early Trial, Boston Researcher Tells AIDS Conference

It's a "mosaic" vaccine that tries to cover the many varieties of HIV around the globe by computer-generating synthetic HIV sequences -- and it could be ready for a big clinical trial in Africa this year.

Support the news

More Boston Headlines

More Boston Headlines